CA3000117A1 - Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing - Google Patents

Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing Download PDF

Info

Publication number
CA3000117A1
CA3000117A1 CA3000117A CA3000117A CA3000117A1 CA 3000117 A1 CA3000117 A1 CA 3000117A1 CA 3000117 A CA3000117 A CA 3000117A CA 3000117 A CA3000117 A CA 3000117A CA 3000117 A1 CA3000117 A1 CA 3000117A1
Authority
CA
Canada
Prior art keywords
hair
trimebutine
composition
skps
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3000117A
Other languages
English (en)
French (fr)
Inventor
Freda D. Miller
David R. Kaplan
Sibel Naska
Kristen Michelle SMITH
Maryline Paris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Original Assignee
Hospital for Sick Children HSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC filed Critical Hospital for Sick Children HSC
Publication of CA3000117A1 publication Critical patent/CA3000117A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA3000117A 2014-09-25 2015-09-25 Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing Abandoned CA3000117A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462055195P 2014-09-25 2014-09-25
US62/055,195 2014-09-25
PCT/CA2015/050966 WO2016044951A1 (en) 2014-09-25 2015-09-25 Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing

Publications (1)

Publication Number Publication Date
CA3000117A1 true CA3000117A1 (en) 2016-03-31

Family

ID=55580010

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3000117A Abandoned CA3000117A1 (en) 2014-09-25 2015-09-25 Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing

Country Status (5)

Country Link
US (1) US9962360B2 (https=)
EP (1) EP3197443A4 (https=)
JP (1) JP2017528505A (https=)
CA (1) CA3000117A1 (https=)
WO (1) WO2016044951A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016044951A1 (en) * 2014-09-25 2016-03-31 The Hospital For Sick Children Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing
HK1251593A1 (zh) 2015-07-24 2019-02-01 豪夫迈‧罗氏有限公司 Bace1抑制剂肽
KR102112736B1 (ko) * 2017-08-01 2020-05-20 주식회사 씨케이바이오텍 탈모 방지 또는 발모 촉진용 조성물
US12285401B2 (en) 2019-04-04 2025-04-29 Daegu-Gyeongbuk Medical Innovation Foundation Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer
US20220362292A1 (en) * 2019-07-26 2022-11-17 Tufts Medical Center, Inc. Adoptive transfer of plasmacytoid dendritic cells to prevent or treat hair loss
WO2022225427A1 (ru) * 2021-04-22 2022-10-27 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые соли [2-(диметиламино)-2-фенилбутил]-3,4,5-триметоксибензоата и их применение
US11744788B2 (en) * 2021-10-27 2023-09-05 James D. Welch Method of encouraging growth and regrowth of hair in human males technical area

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001624A2 (en) * 1989-07-31 1991-02-21 Massachusetts Institute Of Technology Use of calcium antagonists for treating scars
FR2793681B1 (fr) 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
US20080318910A1 (en) * 2005-10-04 2008-12-25 Mistral Pharma, Inc. Controlled-Release Oral Dosage Form
US20110144188A1 (en) * 2006-06-06 2011-06-16 Antibe Therapeutics Inc. Salts of trimebutine and n-desmethyl trimebutine
US8748177B2 (en) * 2008-09-30 2014-06-10 The Hospital For Sick Children Compositions for proliferation of cells and related methods
US9333209B2 (en) * 2012-02-10 2016-05-10 The Board Of Trustees Of The Leland Stanford Junior University Compositions for increasing hair growth
WO2016044951A1 (en) * 2014-09-25 2016-03-31 The Hospital For Sick Children Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing

Also Published As

Publication number Publication date
EP3197443A1 (en) 2017-08-02
US9962360B2 (en) 2018-05-08
WO2016044951A1 (en) 2016-03-31
JP2017528505A (ja) 2017-09-28
EP3197443A4 (en) 2018-03-14
US20170252316A1 (en) 2017-09-07

Similar Documents

Publication Publication Date Title
US9962360B2 (en) Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing
CN113874044B (zh) 皮肤组合物
EP2572701B1 (en) Compositions comprising a retinoid and an nfkb-inhibitor and their methods of use
US20180360792A1 (en) Method of Treatment of Alopecia with Monoterpenoids
WO2011031990A1 (en) Intermittent and pulse lithium treatments for modulating hair growth
KR20110028494A (ko) 탈모 치료용 조성물
EP3494955B1 (en) Cosmetic composition for promoting hair growth
US20230041417A1 (en) Method of determining skin aging
KR101792402B1 (ko) 니코틴산 아데닌 디뉴클레오티드 인산 및 그 유도체를 포함하는 발모 또는 육모 촉진제
BR102014003213A2 (pt) Métodos e composições para melhorar a qualidade dos cabelos utilizando extrato de amora preta
KR102890438B1 (ko) 탈모 증상 완화능을 갖는 두피 유래 펩타이드
EP4470535A1 (en) Composition for preventing, alleviating or treating alopecia or poliosis through aldehyde dehydrogenase 2 regulation
US20240189201A1 (en) Hair serum and supplement
JP6368219B2 (ja) エストロゲン受容体β活性化剤
EP2088991A1 (en) Use of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-alpha-d-mannopyranosyl-oxy)-phenyl]hexane for the preparation of cosmetic compositions
JP7853727B2 (ja) ２型アルデヒド脱水素酵素の調節による脱毛または白毛の予防、改善、または治療用組成物
TW200526222A (en) Method of stimulating hair growth
US20250170150A1 (en) Olfactory receptor 2a4/7 agonist for promoting hair growth and improving aesthetic aspect
CN118973566A (zh) 用于通过调节醛脱氢酶2来预防、缓解或治疗脱发或白发的组合物
CN119326768A (zh) 包含贝美前列素的组合物及其用途
KR101511448B1 (ko) 메이스리그난을 유효성분으로 포함하는 체모성장 저해용 조성물
JP2026506380A (ja) 皮膚の状態または疾患を処置する方法

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20200925